News and events

News and events

European Reference Networks support Ukraine

Pinned

2022_logo-reliefukraine.png

2022 ERN Ukraine logo.jpg

All 24 European Reference Networks (ERNs) launched a dedicated website (https://www.rarediseaseshub4ua.org/) and social media campaign (#ERNcare4Ua & https://www.erncare4ua.com/) to collect information to help health professionals find support for Ukrainian patients with rare diseases: diagnosis, treatment, advice.

With the ongoing war, a large number of Ukrainian citizens have very difficult access to care in Ukraine or are fleeing to EU countries, mainly Eastern ones for the time being. Many of those refugees have or will have health problems. EU governments have clearly committed to ensure adequate healthcare to those refugees, including patients requiring chronic treatments.

Some of those Ukrainian citizens will however suffer from one of the known 6000 rare diseases, like about 6% of the European Union Population. For those disorders, sometimes very rare, expertise is often lacking in many regions or even countries, and treatments may be very expensive and/or difficult to obtain in many centers.

Our 24 ERNs for rare diseases networks are specialized in the diagnosis and treatment of rare/very rare illnesses in each of the 24 medical specialties. They include hospitals (healthcare providers or HCP) and university centers, distributed in most or all EU countries (depending on the ERN), including in EU countries neighbouring Ukraine.


The Coordinators of the 24 European Reference Networks (ERNs) have also issued a statement to support people with Rare Diseases and Complex Conditions affected by the war in Ukraine.

If you are a patient with a genetic tumour risk syndrome coming from Ukraine or a treating physician and you require medical assistance, please contact us at: genturis@radboudumc.nl.

WE ARE HERE TO HELP!

More information on the hub is available here.

 

ERN GENTURIS study published in Lancet Oncology highlights high risk mutations associated with the development of Hereditary Diffuse Gastric Cancer related cancers

Posted on 28 November 2022

 

An international team, led by Carla Oliveira, from the Institute for Research and Innovation in Health of University of Porto (i3S), published a study in the Lancet Oncology journal identifying the alterations in the CDH1 gene that specifically increase the risk of developing cancers associated to Hereditary Diffuse Gastric Cancer (HDGC) syndrome. This study has also defined three new clinical criteria, in addition to those currently used, which will be fundamental to identify families at risk for genetic testing, and to act prophylactically in order to prevent the development of these oncologic diseases of extremely high mortality.

Read more...

 

ERN coordinators meeting in Lyon, France

Posted on 24 November 2022

20221124_ERN coordinators 2022_cropped.jpg

The Coordinators of all 24 European Reference Networks (ERNs) and the Project Managers met in Lyon, France on Tuesday 22 November 2022 to discuss the ERNs achievements and steps towards a sustainable system.

The meeting was focused on ERN sustainability, ERN research collaboration, selecting optimal measurable indicators for a cross-EU healthcare network and exchanging ideas on the future model for financing the use of the Clinical Patient Management System (CPMS). The HUB4Ukraine was also discussed.

 

EJP RD Joint Transnational Call, a funding opportunity for research projects

Posted on 18 November 2022

20221118_EJP RD Joint Transnational Call.png

The EJP RD Joint Transnational Call, a funding opportunity for research projects, will be launched on December 12th.

Topic: Natural History Studies addressing unmet needs in Rare Diseases

The objective of this call is to conduct efficient, innovative and high-quality natural history studies which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy.

An information webinar will be held on December 15th for potential applicants (registration via https://forms.office.com/r/CLYFTuzRyw)

Timetable, contact, and more information about the call are available here: https://www.ejprarediseases.org/joint-transnational-call-2023/

 

Free EJP-RD training on "Biobanking in rare diseases: the Poland experience"

Posted on 5 November 2022

A free EJP-RD training on "Biobanking in rare diseases: the Poland experience" will take place online on 28-29 November 2022. The training is dedicated to scientists in the biomedical sector who want to learn about biobanking standards in Rare Disease research.

Registration deadline: 10 November 2022.
More information:https://www.ejprarediseases.org/event/ejp-rd-training-biobanking-in-rare-diseases-the-poland-experience/

 

Meet the expert teachers from the free course"Diagnosing Rare Diseases: from the Clinic to Research and back"

Posted on 2 November 2022

Mentors and educators, experts in the field, are actively present on the platform to answer the students’ questions between 19 September and 3 December 2022. Take the opportunity to interact with them!

See https://www.ejprarediseases.org/upcoming-update-on-mooc-diagnosis-rare-diseases-from-the-clinic-to-research-and-back/

This course is organized within EJP-RD by ERN GENTURIS member Chrystelle Colas, ERN ITHACA member Laurence Faive, and EURORDIS director Roseline Favresse. Registration is still possible via: https://www.futurelearn.com/courses/rare-genetic-disease

We specifically encourage medical and biomedical science students to register and follow the MOOC.